National Center for Geriatrics and Gerontology
Ōbu 4748511
3 studies enrolling now · 5 studies all time
What they study most
Alzheimer Disease, Alzheimer's Disease, Amyloid, Cognitive Dysfunction, Dementia, Healthy, Lewy Body Disease, Plaque, Amyloid, Synucleinopathies
Studies at this site
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). — Recruiting now
- A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) — Recruiting now
- A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
- A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling